Dupuytren'sContractureTreatment near Englewood, NJ

Biography: Dr. James Gladstone, MD is an Orthopedic Surgery Specialist who practices in New York, NY. He is 63 years old and has been practicing for 35 years. Dr. James Gladstone, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Andrew Hecht, MD is an Orthopedic Surgery Specialist who practices in New York, NY. He is 58 years old and has been practicing for 31 years. Dr. Andrew Hecht, MD is affiliated with Mount Sinai Hospital.

Care Philosophy: Clinical Electrophysiology is an exciting field with many new advancements. We have many new therapies that can help our patients feel better and live longer. It is very rewarding to be able to offer patients these new and proven therapies to make a positive impact in their lives.

Care Philosophy: The center specializes in advanced systolic and diastolic heart failure, left ventricular assist device implantation, evaluation for cardiac transplantation, vavular disease and evaluation and treatment of pulmonary hypertension. My area of clinical as well as research interest is in evaluation and management of diastolic heart failure or heart failure with preserved ejection fraction and its effects on pulmonary vasculature.

Biography: Dr. Sonal Kumar graduated summa cum laude from Washington University in St. Louis in 2002 and obtained her medical degree in 2006 from Washington University School of Medicine. She subsequently completed internal medicine internship and residency at Barnes-Jewish Hospital - Washington University School of Medicine and then Gastroenterology and Hepatology fellowship at Brigham and Women's Hospital - Harvard University. During fellowship, she also received her Master of Public Health from the Harvard School of Public Health. Dr. Kumar is board certified in Internal Medicine and Gastroenterology/Hepatology.Dr. Kumar is an Assistant Professor of Medicine and currently is the Director of Clinical Hepatology at Weill Cornell Medical College. Her clinical interests include non-alcoholic fatty liver disease, viral hepatitis, genetic/autoimmune liver disease and alcoholic liver disease. Dr. Kumar also has a background in clinical research and is involved in multiple clinical trials. She is a member of the American Association for the Study of Liver Diseases, the European Association for the Study of the Liver, the Empire Liver Foundation, and the American College of Gastroenterology. Dr. Kumar also routinely performs upper endoscopy and colonoscopy.

Biography: Dr. Evelyn Horn is the Director of the Perkin Heart Failure Center of Weill Cornell, specializing in Heart Failure, Pulmonary Hypertension, and Mechanical Circulatory Support.Patients referred to the Center include those with diagnoses of systolic heart failure, valvular heart disease, preserved EF heart failure; pulmonary vascular disease - idiopathic, associated and secondary.Evelyn M. Horn, M.D. is a graduate of Brown University, Mount Sinai Medical School where she also was a medical intern and resident. She completed cardiology at the Cedars Sinai/UCLA program and thereafter spent 2 years as a research fellow at Columbia College of Physicians and Surgeons understanding the beta adrenergic G protein complex in heart failure, the denervated heart and models of arrhythmias. She remained at Columbia University Medical Center in the Divisions of Circulatory Physiology and Cardiology Center for Advanced Cardiac Care where she was at various times, Director of the Circulatory Physiology fellowship program, Director of Clinical Services for Heart Failure, Associate Director of the combined Pediatric & Adult Pulmonary Hypertension Center and Director of the Pulmonary Vascular program of the Center for Advanced Cardiac Care. She also was the director of the High Risk Cardiac Obstetrical program. She received numerous awards as clinician educator, continues to participate in clinical research in the areas of cardiac and vascular remodeling in heart failure and pulmonary hypertension.The Heart Failure program provides management of advanced heart failure (both systolic and diastolic), congenital heart disease, perioperative management of conventional cardiac surgical patients (high risk patients and high risk valve surgery), and ventricular assist devices. The center also offers rare expertise in the management of pulmonary hypertension, including idiopathic pulmonary hypertension and pulmonary hypertension associated with diseases such as connective tissue disease, congenital heart disease as well as a huge number of patients who have it in association with left heart disease and others have it associated with lung disease, certain hematological diseases or liver disease. Pulmonary hypertension and right heart failure complicates the management of about 1/3 of the patients with heart failure. In many, right heart failure follows left heart failure but management of difficult "cases" may require a special expertise and understanding of the interdependence of the right and the left ventricles. If cases become complicated by secondary pulmonary hypertension or right heart failure, most of Dr. Horn's colleagues seek out the "right heart doctor," as she has sometimes been called or the combined left and right heart doc.The phenotype of heart failure has multiple etiologies, and not all heart failure behaves the same way. Because of the nuances and subtleties involved in advanced heart failure, she stresses the importance of the multidisciplinary, collaborative center. Moreover, Dr. Horn points to the center's expertise in identifying the appropriateness and the optimal timing of therapeutic interventions. "We have fantastic technologies and therapies available, but these may not be in every patient's best interest," she explains. "It is essential to understand when therapies will or will not work, and when one has to move beyond them, perhaps to mechanical assist devices or heart transplantation for heart failure and lung transplantation for pulmonary hypertension. If we wait too long, we may have missed the opportunity to treat a patient, but no one wants to resort to devices or transplantation before a patient absolutely needs it."Dr. Horn's clinical research interests have been in ventricular and vascular remodeling in pulmonary hypertension and heart failure. Specific areas have included RV imaging, pulmonary hypertension outcome studies, use of vasopressin in pulmonary hypertension, endothelial dysfunction in pulmonary hypertension, RV dysfunction in the perioperative patient population, complications of pulmonary hypertension therapy, and assessment of the non PAH pulmonary hypertension patient population. She has been actively involved in the care of patients with valvular heart disease and in particular comorbidities of ventricular dysfunction and/or pulmonary vascular disease. She has been actively involved in the care of patients needing ventricular assist device therapies as a bridging or destination device. Along with colleagues, she has authored papers in the field of newer therapies for pulmonary hypertension, epidemiological assessments of patients with pulmonary hypertension, genetics of pulmonary hypertension, and markers of vascular dysfunction. She has been involved in industry sponsored heart failure and pulmonary hypertension studies, industry sponsored investigator initiated studies and collaborative NIH studies in Heart Failure and Pulmonary Hypertension. She has also been the liaison to high risk cardiac OB programs for the care of the complicated cardiac OB patient.Research and invited lectures have been presented at major National and International meetings. She is a fellow of the International Pulmonary Vascular Research Institute, helping to establish ISLHT Pulmonary Hypertension Committee and has been the recipient of teaching awards at Columbia University. Dr. Horn has created a NY Pulmonary Hypertension consortium, a network of a dozen specialists from the tri-state area, to encourage ongoing collaborative studies in pulmonary hypertension.

Care Philosophy: Dr. Sharaiha is dedicated to putting her patients first. She has a special interest in the endoscopic treatment of obesity and the diseases of the pancreas and biliary tract, including pancreatitis, fluid collection, sphincter of oddi dysfunction and pancreatic cancer. She is grant funded for trials with malignant biliary obstruction. She sees patients for advanced endoscopic procedures, staging of GI cancers, and treatment or removal of early cancer lesions, surveillance and ablation of pancreatic cysts, and for obesity treatment.

Biography: Dr. David Wan is an Assistant Professor of Medicine and Attending Physician at the New York Presbyterian-Weill Cornell Medical Center in The Division of Gastroenterology and Hepatology.Dr. Wan earned his Bachelor of Science in Neuroscience at Brown University prior to getting his medical degree at NYU where he graduated Alpha Omega Alpha. He completed his residency in Internal Medicine at New York Presbyterian-Weill Cornell Medical Center and his Gastroenterology fellowship at NYU.Dr. Wan has a wide variety of interests within gastroenterology and hepatology. One of his main roles will be in the training of gastroenterology fellows in endoscopy/colonoscopy and the inpatient consultation service. He is a member of the American College of Gastroenterology and the American and New York Societies of Gastrointestinal Endoscopy.

Biography: Dr. Baron Lonner, MD is an Orthopedic Surgery Specialist who practices in New York, NY. He is 61 years old and has been practicing for 36 years. Dr. Baron Lonner, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Biography: Dr. Alyson Fox earned her BA in Public Health at the Johns Hopkins University prior to attending the Mount Sinai School of Medicine. She completed her residency in Internal Medicine at NewYork-Presbyterian Weill Cornell Medical Center, where she served as assistant chief resident. She completed her Gastroenterology fellowship at the University of Pennsylvania. While at Penn, she completed a Masters in Clinical Epidemiology and served as chief fellow. She completed her advanced fellowship training in Advanced Transplant Hepatology at the University of California, San Francisco and was named clinical fellow of the year by the Department of Medicine. Dr. Fox's clinical practice is focused on the management of patients with a variety of liver diseases including viral hepatitis, alcoholic and non-alcoholic fatty liver diseases, inherited and autoimmune liver diseases and liver cancers. As a transplant hepatologist, she has advanced training in the management of the complications of end stage liver disease and caring for patients both pre- and post- liver transplantation. As the medical director of the adult transplant program, she oversees the program operations, protocols, outcomes and initiatives. When she is not caring for patients, she is active as a course director and educator at the Columbia University Vagelos College of Physicians and Surgeons. Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver